Several breakthroughs in recent years have rapidly shifted the treatment landscape for advanced HCC.
Timothy J. Brown, MD
Advertisement
Articles by Timothy J. Brown, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Dr Pant on the Potential Significance of Daraxonrasib for PDAC Management
2
Epcoritamab Misses Sole US Primary End Point of Overall Survival in R/R DLBCL
3
CHMP Recommends Sacituzumab Govitecan Plus Pembrolizumab for Frontline PD-L1+ Metastatic TNBC
4
CHMP Recommends T-DXd Plus Pertuzumab for First-Line HER2-Positive Metastatic Breast Cancer
5